Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Charming Shoppes Q4 Loss Reduces - Quick Facts

Charming Shoppes Inc. (CHRS: Quote) posted a narrower fourth quarter GAAP net loss of 13.2 million or $0.11 per share compared with $30.4 million or $0.26 per share loss a year ago. On a non-GAAP basis, net loss also narrowed to $0.06 per share from last year's $0.08 per share, both periods excluding restructuring and other items. On average, 4 analysts polled by Thomson Reuters expected loss per share of $0.02 for the quarter. Analysts' estimates typically exclude one-time items.

Net sales were $559.1 million for the recent quarter, a 2.9% decrease from $575.8 million in the prior-year period. The $16.7 million decrease includes the impact of operating 207 fewer stores than in the previous year, partially offset by a consolidated comparable-store sales rise of 1%. Three analysts estimated revenues of $542.27 million for the quarter.

Click here to receive FREE breaking news email alerts for Charming Shoppes Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After turning in a lackluster performance for much of the session, stocks managed to end Wednesday's trading mostly higher. The gains lifted the Dow and the S&P 500 to new record closing highs, while the Nasdaq reached its best levels since 2000. Half of Americans agree with the changes to immigration policy announced by President Barack Obama last week, according to a CNN/ORC poll, although a majority opposes using executive orders to implement those policies. While Mitt Romney has said he has no plans to run for president again, the results of a Quinnipiac University national poll released Wednesday show the former Massachusetts Governor leading a group of potential Republican presidential candidates.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.